T. B. Drüeke, Cell Biology of Parathyroid Gland Hyperplasia in Chronic Renal Failure, J Am Soc Nephrol. 1 juin, vol.11, issue.6, pp.1141-52, 2000.

J. Silver, R. Kilav, and T. Naveh-many, Mechanisms of secondary hyperparathyroidism, Am J Physiol-Ren Physiol. 1 sept, vol.283, issue.3, pp.367-76, 2002.

A. Levin, G. L. Bakris, M. Molitch, M. Smulders, J. Tian et al., Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease, Kidney Int. janv, vol.71, issue.1, pp.31-39, 2007.

S. Moe, T. Drüeke, J. Cunningham, W. Goodman, K. Martin et al.,

, Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int. juin, vol.69, issue.11, pp.1945-53, 2006.

C. Kdigo and . Ki,

D. Sur,

A. M. Alem, D. J. Sherrard, D. L. Gillen, N. S. Weiss, S. A. Beresford et al., Increased risk of hip fracture among patients with end-stage renal disease, Kidney Int. juill, vol.58, issue.1, pp.396-405, 2000.

. Stehman-breen, . Co, D. J. Sherrard, A. M. Alem, D. L. Gillen et al., Risk factors for hip fracture among patients with end-stage renal disease, Kidney Int, vol.58, issue.5, pp.2200-2205, 2000.

F. H. Glorieux, R. Travers, A. Taylor, J. R. Bowen, F. Rauch et al., Normative data for iliac bone histomorphometry in growing children, Bone. févr, vol.26, issue.2, pp.103-112, 2000.

S. M. Ott, Histomorphometric measurements of bone turnover, mineralization, and volume, Clin J Am Soc Nephrol CJASN. nov, vol.3, issue.3, pp.151-156, 2008.

, Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), KDIGO 2017 Clinical, vol.7, p.59, 2017.

P. Delanaye, J. Souberbielle, L. Jean, G. Cavalier, and E. , Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts, Nephrol Dial Transplant. 1 mai, vol.29, issue.5, pp.997-1004, 2014.

P. Ureña and M. De-vernejoul, Circulating biochemical markers of bone remodeling in uremic patients, Kidney Int. juin, vol.55, issue.6, pp.2141-56, 1999.

P. Ureña, M. Hruby, A. Ferreira, K. S. Ang, and M. C. De-vernejoul, Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients, J Am Soc Nephrol JASN. mars, vol.7, issue.3, pp.506-518, 1996.

S. Salam, O. Gallagher, F. Gossiel, M. Paggiosi, A. Khwaja et al., Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy, J Am Soc Nephrol. mai, vol.29, issue.5, pp.1557-65, 2018.

A. R. Bervoets, G. B. Spasovski, G. J. Behets, G. Dams, M. H. Polenakovic et al., Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients, Am J Kidney Dis. mai, vol.41, issue.5, pp.997-1007, 2003.

P. Evenepoel and J. Bover, Ureña Torres P. Parathyroid hormone metabolism and signaling in health and chronic kidney disease, Kidney Int. 1 déc, vol.90, issue.6, pp.1184-90, 2016.

Y. Pei, G. Hercz, C. Greenwood, G. Segre, A. Manuel et al., Risk factors for renal osteodystrophy: A multivariant analysis, J Bone Miner Res. 1 janv, vol.10, issue.1, pp.149-56, 1995.

G. Coen, P. Ballanti, E. Bonucci, S. Calabria, M. Centorrino et al., Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc. sept, vol.13, issue.9, p.302, 1998.

E. Cavalier, P. Delanaye, J. Collette, J. Krzesinski, and J. Chapelle, Evaluation of different bone markers in hemodialyzed patients, Clin Chim Acta. sept, vol.371, issue.1, pp.107-118, 2006.

P. J. Marie, A. Lomri, M. Vernejoul, C. Morieux, A. Graulet et al., Relationships between Histomorphometric Features of Bone Formation and Bone Cell Characteristics in Vitro in Renal Osteodystrophy, J Clin Endocrinol Metab. déc, vol.69, issue.6, pp.1166-73, 1989.

P. Ureña, A. Ferreira, C. Morieux, T. Drüeke, C. De-vernejoul et al.,

, PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats, Nephrol Dial Transplant, vol.11, issue.10, p.16, 1996.

P. Ureña, M. Mannstadt, M. Hruby, A. Ferreira, F. Schmitt et al., Parathyroidectomy does not prevent the renal PTH/PTHrP receptor downregulation in uremic rats, Kidney Int. 1 juin, vol.47, issue.6, pp.1797-805, 1995.

P. Delanaye, B. E. Dubois, F. Jouret, J. Krzesinski, O. Moranne et al.,

, Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: Is it so simple?, Clin Chim Acta. 18 févr, vol.417, pp.35-43, 2013.

C. Sánchez, F. López-barea, J. Sánchez-cabezudo, A. Bajo, A. Mate et al., Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study, Nephrol Dial Transplant. 1 juin, vol.19, issue.6, pp.1587-93, 2004.

G. Jean, C. Chazot, and B. Charra, 12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers, Clin Nephrol. juill, vol.68, issue.1, p.4, 2007.

G. Jean, J. Souberbielle, C. Lorriaux, B. Mayor, J. Hurot et al.,

, Les formes cliniques et biologiques de l'hyperparathyroïdie secondaire en dialyse, Néphrologie Thérapeutique. févr, vol.8, issue.1, p.40, 2012.

N. Hamdy, J. A. Kanis, M. Beneton, C. B. Brown, J. R. Juttmann et al., Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure, BMJ. 11 févr, vol.310, issue.6976, p.63, 1995.

P. Kandula, M. Dobre, J. D. Schold, M. J. Schreiber, R. Mehrotra et al.,

, Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials

, Clin J Am Soc Nephrol. 1 janv, vol.6, issue.1, pp.50-62, 2011.

V. Belozeroff, W. G. Goodman, L. Ren, and K. Kalantar-zadeh, Cinacalcet Lowers Serum Alkaline Phosphatase in Maintenance Hemodialysis Patients, Clin J Am Soc Nephrol. 1 mars, vol.4, issue.3, pp.673-682, 2009.